Skip to content

Angelica PeeblesJournalist

@angelicalavito

RSS Feed

Biogen Lays Out Awaited Alzheimer’s Data in Obscure Journal

Prognosis

Biogen CEO to Leave After Alzheimer’s Drug Fails to Get Covered

5/3/22, 7:20 AM EDT

5/3/22, 7:20 AM EDT

Key Speakers At The 2021 Milken Conference

Prognosis

World Must Leverage Genomics to Fight Pandemics, Illumina CEO Says

4/19/22, 12:20 PM EDT

4/19/22, 12:20 PM EDT

William Burke

Medicare’s Strict Alzheimer’s Policy Raises Ante for Drugmakers

4/9/22, 8:15 AM EDT

4/9/22, 8:15 AM EDT

Monoclonal Antibody Treatment In Demand Amid Rise In Covid-19 Cases

Prognosis

Covid Antibody Therapy From Vir, Glaxo Loses U.S. Authorization

4/6/22, 3:05 AM EDT

4/6/22, 3:05 AM EDT

relates to Bluebird Bio Cuts Expenses and Its Workforce to Navigate Cash Crunch

Bluebird Bio Cuts Expenses and Its Workforce to Navigate Cash Crunch

4/5/22, 9:36 AM EDT

4/5/22, 9:36 AM EDT

Nobel Prize for Chemistry 2020

Prognosis

Crispr Pioneer Expects to See Gene-Edited Babies Within 25 Years

4/4/22, 10:00 AM EDT

4/4/22, 10:00 AM EDT

A Walgreens Boots Alliance Store Ahead Of Earnings Figures

Walgreens Falls as Investors Worry That Covid Gains Won’t Last

3/31/22, 10:41 AM EDT

3/31/22, 10:41 AM EDT

RF brain Alzheimers

Prognosis

Vertex to Advance Non-Opioid Pain Therapy After Positive Results

3/31/22, 8:07 AM EDT

3/31/22, 8:07 AM EDT

relates to Vir, Glaxo Therapy Loses Clearance in Areas Where BA.2 Reigns

Prognosis

Vir, Glaxo Therapy Loses Clearance in Areas Where BA.2 Reigns

3/25/22, 4:45 PM EDT

3/25/22, 4:45 PM EDT

Henderson And Las Vegas Residents Receive Covid-19 Vaccination

Prognosis

Pfizer, Moderna Sued by Alnylam in New Fight Over Covid Shots

3/17/22, 10:26 AM EDT

3/17/22, 10:26 AM EDT

relates to Biogen Lays Out Awaited Alzheimer’s Data in Obscure Journal

Prognosis

Biogen Lays Out Awaited Alzheimer’s Data in Obscure Journal

3/16/22, 2:06 PM EDT

3/16/22, 2:06 PM EDT

relates to After Pandemic Success, Vir Looks for a Follow-Up

Business

After Pandemic Success, Vir Looks for a Follow-Up

The biotech startup scored with an effective monoclonal antibody. Now it must show it can tackle some of the world’s most prevalent diseases.

3/15/22, 6:00 AM EDT

3/15/22, 6:00 AM EDT

CVS Health Locations Ahead Of Earnings Figures

CVS Health Ousts Employees Following Probe of Misconduct

3/11/22, 3:43 PM EST

3/11/22, 3:43 PM EST

Amazon Hires Providence Hospital Executive for Health Role

3/11/22, 4:01 PM EST

3/11/22, 4:01 PM EST

biotech lab technician

Bluebird Bio Sinks on CFO’s Exit, Cash Squeeze

3/7/22, 1:05 PM EST

3/7/22, 1:05 PM EST

relates to Bluebird Bio Says Cash Crunch Raises ‘Going Concern’ Risk

Bluebird Bio Says Cash Crunch Raises ‘Going Concern’ Risk

3/4/22, 6:58 PM EST

3/4/22, 6:58 PM EST

1489652485_peptidream hp social

Intellia Therapeutics Sinks as Patent Ruling Overshadows Crispr Promise

3/1/22, 2:04 PM EST

3/1/22, 2:04 PM EST

dpa-story: Crispr

Prognosis

Crispr Ruling Invalidates Some Biotech Company Patents

2/28/22, 10:29 PM EST

2/28/22, 10:29 PM EST

Crispr

Intellia Crispr Therapy Cuts Abnormal Liver Protein for Months

2/28/22, 4:01 PM EST

2/28/22, 4:01 PM EST

Sotrovimab Covid-19 Antibody Drug

Prognosis

Vir Falls After FDA Narrows Guidance on Covid Antibody Therapy

2/25/22, 10:13 AM EST

2/25/22, 10:13 AM EST